Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Judy, Hopfield"'
Publikováno v:
Matter
The Terasaki Institute for Biomedical Innovation is an independent non-profit organization and uses an integrative approach to innovate personalized health. The Institute draws on its scientific, entrepreneurial, and engineering skill set to transfor
Publikováno v:
Journal of Immunological Methods. 486:112847
The screening for IgG subclass donor-specific antibodies (DSAs) in allograft recipients uses IgG1-4 subclass-specific monoclonal antibodies (mAbs) that should be mono-specific. The cross-reactivity discrepancies reported for IgG subclass-specific mAb
Autor:
Michiko, Taniguchi, Lorita M, Rebellato, Kimberly P, Briley, Carl E, Haisch, Paul, Bolin, Nubia, Banuelos, Judy, Hopfield, Paul I, Terasaki, Matthew J, Everly
Publikováno v:
Clinical transplants. 31
Human leukocyte antigen (HLA) antibodies are a major cause of graft loss in mismatched transplant recipients. However, the time to graft loss resulting from antibody induced injury is unpredictable. The unpredictable nature of antibodies may be relat
Publikováno v:
Transplantation. 90:1493-1498
Background. Proteasome inhibition abrogates donor-specific anti-human leukocyte antigen (HLA) antibody (DSA) in patients posttransplant. However, its effects on protective humoral immunity to vaccine antigens remain unknown. Herein, we report on bort
Autor:
Mepur H, Ravindranath, Dong, Zhu, Tho, Pham, Vadim, Jucaud, Judy, Hopfield, Satoru, Kawakita, Paul I, Terasaki
Publikováno v:
Clinical transplants.
Healthy individuals have natural antibodies (Abs) reacting to allo-human leukocyte antigen (HLA)-la. This could be due to the presence of anti-HLA-E immunoglobulin G (IgG), which was revealed to recognize the peptides shared between HLA-E and HLA-la
Autor:
Ohe Hidenori, Michiko Taniguchi, Duska Dragun, Paul I. Terasaki, Ralf Dechend, Harald Heidecke, Shinji Uemoto, Gabriela Riemekasten, Kai Schulze-Forster, Judy Hopfield, Curtis Y. Maehara
Publikováno v:
Human Immunology. 75:43-44
Aim While the importance of non-HLA antibodies’ (Abs) pathological role has been emerging in kidney transplantation, the involvement of non-HLA Abs after liver transplantation remains poorly understood. Our study explored the effect of Abs against
Autor:
Kimberly P. Briley, Judy Hopfield, Paul I. Terasaki, Michiko Taniguchi, Paul G. Catrou, Lorita M. Rebellato
Publikováno v:
Transplantation Journal. 94:331
Autor:
Lorita M. Rebellato, Michiko Taniguchi, Junchao Cai, Judy Hopfield, Paul I. Terasaki, Paul G. Catrou, Kimberly P. Briley
Publikováno v:
Human Immunology. 73:99
Aim Antibodies against AT1R have been observed in patients with acute rejection of kidney and chronic rejection of heart transplants. Our study sought to determine if AT1R antibodies are associated with graft failure after rejection. Methods We enrol
Publikováno v:
Human Immunology. 72:S81
Autor:
Nadim El-Awar, Paul I. Terasaki, Cristina von Glehn, Matthew J Everly, Judy Hopfield, Anh Nguyen
Publikováno v:
Human Immunology. 71:S150